Tuesday, January 10, 2023

Gist Healthcare joins healthcare management consultancy group Kaufman Hall. Biogen’s latest Alzheimer’s drug lecanemab was granted accelerated approval by the FDA. And, the FTC has proposed a ban on non-compete agreements, which could impact how the healthcare industry operates. That's coming up on today's episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Jan 10, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Tuesday, January 10, 2023

0:00 7:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 7 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on January 10, 2023.

Can I download this The Gist Healthcare Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!